DocuSign, Inc. (NASDAQ:DOCU) Stock Position Lifted by MetLife Investment Management LLC

MetLife Investment Management LLC increased its holdings in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 863.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,375 shares of the company's stock after acquiring an additional 110,568 shares during the period. MetLife Investment Management LLC owned about 0.06% of DocuSign worth $11,096,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. FMR LLC raised its position in shares of DocuSign by 178.2% in the fourth quarter. FMR LLC now owns 6,101,024 shares of the company's stock valued at $548,726,000 after purchasing an additional 3,908,139 shares during the period. Invesco Ltd. lifted its stake in DocuSign by 283.9% in the fourth quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock worth $310,048,000 after acquiring an additional 2,549,310 shares during the period. Norges Bank bought a new stake in DocuSign during the 4th quarter valued at approximately $223,196,000. Arrowstreet Capital Limited Partnership grew its holdings in DocuSign by 201.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,158,311 shares of the company's stock worth $194,118,000 after purchasing an additional 1,442,639 shares during the period. Finally, Amundi raised its holdings in DocuSign by 565.8% in the fourth quarter. Amundi now owns 1,379,575 shares of the company's stock worth $123,486,000 after buying an additional 1,172,368 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 16,111 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total transaction of $1,340,435.20. Following the completion of the transaction, the chief financial officer now owns 93,960 shares of the company's stock, valued at approximately $7,817,472. This represents a 14.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the transaction, the director now directly owns 8,270 shares in the company, valued at $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 55,851 shares of company stock worth $4,607,439 in the last three months. Corporate insiders own 1.66% of the company's stock.

DocuSign Trading Up 5.3 %

NASDAQ:DOCU traded up $3.91 during mid-day trading on Wednesday, hitting $78.11. The stock had a trading volume of 1,645,535 shares, compared to its average volume of 2,734,824. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The company has a market capitalization of $15.82 billion, a PE ratio of 16.10, a PEG ratio of 6.94 and a beta of 1.20. The stock has a 50-day simple moving average of $80.55 and a two-hundred day simple moving average of $83.34.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.02. The firm had revenue of $776.25 million for the quarter, compared to analysts' expectations of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm's revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.76 EPS. Sell-side analysts predict that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DOCU shares. Hsbc Global Res raised DocuSign from a "moderate sell" rating to a "hold" rating in a research report on Friday, April 11th. Citigroup raised their price objective on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price target on shares of DocuSign in a research note on Friday, March 14th. Jefferies Financial Group reduced their target price on DocuSign from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, March 31st. Finally, JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and lifted their price target for the company from $70.00 to $75.00 in a research report on Monday, March 10th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $92.46.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.